These data suggest that children who develop early insulin autoimmunity are not deficient in their maternally transferred anti-CVB antibodies, and that the status of maternal anti-CVB antibodies does not influence anti-CVB antibody responses that develop later in life. This evidence concerns the gene INS and Autoimmunity.